Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Study: Suicides rise in wake of 'black box' warnings on antidepressants
Fierce Pharma
Thursday, June 19, 2014 - 10:55am
tags:
antidepressants, suicide, black box
NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis
Fierce Pharma
Thursday, June 19, 2014 - 10:36am
tags:
NICE, Pradaxa, Xarelto, bloodthinners, Eliquis, Bayer, JNJ, Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim
StemCells early AMD data a 'best case' outcome, says Maxim
The Fly on the Wall
Thursday, June 19, 2014 - 10:19am
tags:
StemCells, dry age-related macular degeneration
Is This MannKind's Biggest Risk?
Motley Fool
Thursday, June 19, 2014 - 9:22am
tags:
MannKind, diabetes, Afrezza
Prestigious Cancer Hospital Rebukes Northwest Bio for 'Inappropriate' Data Disclosures
TheStreet.com
Thursday, June 19, 2014 - 8:55am
tags:
Northwest Biotherapeutics, MD Anderson Cancer Center, DCVax Direct
Sovaldi And Drug Pricing: The United States Of Saps (GILD)
Seeking Alpha
Thursday, June 19, 2014 - 8:54am
tags:
Sovaldi, drug pricing, hepatitis C, Gilead Sciences
IPO Preview: Ardelyx (ARDX)
Seeking Alpha
Thursday, June 19, 2014 - 8:53am
tags:
IPOs, Ardelyx, Sanofi, AstraZeneca
Drug-maker Valeant begins exchange offer for Allergan
Yahoo/Reuters
Thursday, June 19, 2014 - 8:51am
tags:
Valeant Pharmaceuticals, Allergan, hostile bid, M&A
Medtronic vs. Johnson & Johnson: Meet the Market's Biggest New Rivalry
Motley Fool
Wednesday, June 18, 2014 - 5:46pm
tags:
Medtronic, JNJ, devices
OncoMed: FDA places partial clinical hold on Phase 1 trials of FZD8-Fc
The Fly on the Wall
Wednesday, June 18, 2014 - 5:41pm
tags:
OncoMed, FDA, FZD8-Fc
Pfizer XELJANZ Phase 3 findings support safety, efficacy
Yahoo/Fly on the Wall
Wednesday, June 18, 2014 - 5:39pm
tags:
Pfizer, Xeljanz, rheumatoid arthritis
Big biotech booms while pharma payrolls wither
Fierce Biotech
Wednesday, June 18, 2014 - 4:27pm
tags:
biotech, Big Pharma
Emerging Markets Offer A New Channel Of Demand For Pharmaceutical Products
Forbes
Wednesday, June 18, 2014 - 4:26pm
tags:
emerging markets
Teva Pharm's chairman Phillip Frost to step down by year end
Yahoo/Reuters
Wednesday, June 18, 2014 - 11:27am
tags:
Teva Pharmaceuticals, Phillip Frost
The Race To The Market: Anacor and Valeant
Motley Fool
Wednesday, June 18, 2014 - 11:26am
tags:
Valeant Pharmaceuticals, Anacor, Onychomycosis, Jublia, Kerydin
Allergan, Actavis Top Big Cap Pharmas Amid M&A Flurry
Investors.com
Wednesday, June 18, 2014 - 10:33am
tags:
Valeant Pharmaceuticals, M&A, Actavis, Allergan
New Alkermes Schizophrenia Drug -- An Important Advance With Social Benefits
Forbes
Wednesday, June 18, 2014 - 10:11am
tags:
aripiprazole lauroxil, schizophrenia, Alkermes
Novartis overhaul expected to improve core operating income margin
The Fly on the Wall
Wednesday, June 18, 2014 - 10:07am
tags:
reorganization, Novartis Business Services, Novartis
Vertex Licenses VX-787 to Janssen Pharmaceuticals for the Treatment of Influenza
Yahoo/BusinessWire
Wednesday, June 18, 2014 - 9:27am
tags:
VX-787, Vertex Pharmaceuticals, Janssen
Zalicus Licenses Sodium Channel Pain Modulation Program
Yahoo/BusinessWire
Wednesday, June 18, 2014 - 8:39am
tags:
Zalicus, pain management, AnaBios

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.